Accsys Technologies Plc holds a large number of patents related to the acetylation of wood, a process that makes the wood stronger and prevents decay. The primary focus is the production and licensing of Accoya® solid wood and Tricoya® wood elements technology, used for windows, doors, decking, cladding and other construction products. Accoya is manufactured at the company’s plant in the Netherlands using mainly a type of pine grown sustainably in New Zealand. Accsys are in the process of doubling the capacity of this plant at the same time as building a new plant in conjunction with BP and Medite to produce Tricoya near Hull.
Exchange: London AIM (AXS) and NYSE Euronext (AXS)
Financial Data from Exchange website: LSE summary
Recent Financial Report: Interim results to September 2016
Accsys originally concentrated on selling licenses for the production of their products, but this was not successful so since 2015 the company has put their efforts into expanding their own production capacity (partly backed by a guaranteed purchase agreement with Solvay, a Belgian chemical company).
Since the US company Eastman Chemical stopped making similar products in 2012, Accsys apparently have a world-wide monopoly. They are marketed as having strength and durability similar to PVC or Aluminium, but with less environmental impact.
19 Lancaster Place,
London WC2E 7EN
T: +44 (0) 20 7421 4300
F: +44 (0) 20 7240 8534
Chairman: Patrick Shanley
CEO: Paul Clegg
Short description: Synthetic wood technology
Fields of Interest: Bioenergy